Long-term outcome after perioperative chemotherapy and surgery for gastro-esophageal adenocarcinoma
Five-year OS was 4%-6% points inferior to RCTs. Pretreatment white blood cell counts, but not postoperative, could supplement clinical prognostic factors. Downstaging by preoperative chemotherapy was prognostic but correlated strongly with pretreatment clinical stage.
Authors
- Susy Shim (ORCID: https://orcid.org/0000-0001-8226-0612)
- Lene Bæksgaard (ORCID: https://orcid.org/0000-0003-4662-5164)
- Jakob B. Sørensen (ORCID: https://orcid.org/0000-0001-5465-3769)
- Anders Christian Larsen (ORCID: https://orcid.org/0000-0003-2489-0848)
- Morten Ladekarl (ORCID: https://orcid.org/0000-0002-0182-1228)
- Per Pfeiffer (ORCID: https://orcid.org/0000-0002-2925-0586)
- Marianne Nordsmark (ORCID: https://orcid.org/0000-0002-8167-1273)
Institutions
- University of Southern Denmark (DK)
- Aarhus University (DK)
- Aalborg University Hospital (DK)
- Odense University Hospital (DK)
- Aarhus University Hospital (DK)
- Rigshospitalet (DK)
- Aalborg University (DK)
Publication Details
- Journal
- ESMO Gastrointestinal Oncology
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1016/j.esmogo.2025.100183
- Citations
- 1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.52